DVP/ FPLC system
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cbersacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration's Laboratory of Immunoregulation is seeking a Fast Protein Liquid Chromatography (FPLC) system to support research on SARS-CoV-2 spike protein structure and function. The procurement focuses on purifying peptides and proteins for studies examining neutralization of the virus by vaccine-generated antibodies, infection-derived antibodies, and fusion inhibitors such as peptides. The solicitation is forecasted for release on May 1, 2026, with an estimated award date of July 1, 2026.
The estimated contract award value ranges between $25,000 and $250,000, with the procurement classified under NAICS 334516 for Analytical Laboratory Instrument Manufacturing. This is a new requirement with no set-aside provisions. Interested vendors should direct inquiries to the FDA's Center for Biologics Evaluation and Research acquisitions mailbox at cbersacquisitions@fda.hhs.gov, referencing Purchase Order number 75F40124P00179.
Forecast text
The Laboratory of Immunoregulation (OVRR/DVP) requires a Fast Protein Liquid Chromatography (FPLC) system for purifying peptides and proteins for a project studying the SARS-CoV-2 spike protein structure and function and how this relates to neutralization of the SARS-CoV-2 virus by antibodies generated by vaccines and infections or neutralization by fusion inhibitors such as peptides.
PO# 75F40124P00179
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast